What is the impact on work of osteoporotic fractures in active patients? A retrospective fracture-liaison-service study-Optiwork 1.


Journal

Archives of osteoporosis
ISSN: 1862-3514
Titre abrégé: Arch Osteoporos
Pays: England
ID NLM: 101318988

Informations de publication

Date de publication:
08 03 2022
Historique:
received: 21 10 2020
accepted: 05 05 2021
entrez: 9 3 2022
pubmed: 10 3 2022
medline: 16 3 2022
Statut: epublish

Résumé

Osteoporotic fractures have economic consequences and can alter the quality of life. Nevertheless, the direct impact on work has been infrequently reported. Our objective was to estimate the proportion of working patients resuming paid employment within the 3 months following an osteoporotic fracture, and to assess the consequences on their productivity and quality of life. Patients aged between 45 and 64, screened by the Fracture Liaison Service of Hospital Paris Saint Joseph for a fragility fracture occurring between January 2017 and December 2018, and being paid employees at the time of the fracture, were included retrospectively. Medical data were extracted from electronic medical records. Self-reporting questionnaires concerning work activity and quality of life before and after the fracture were sent by post. Overall, 121 patients were included, with a mean age of 55.8; 82.6% of patients were female. Fracture of the lower extremity of the radius was the most frequent (38.2%), followed by the upper extremity of the humerus (23.1%). After the index fracture, 82.6% of the patients went back to work, including 76.0% within 3 months following the fracture. The median time to return to work was 2.2 months. Moreover, 19.8% of patients required adaptations of their current work. Osteoporotic fractures have a direct impact on work activity, causing work stoppages. Productivity at work and quality of life were also impacted. Further studies are needed to confirm these findings.

Identifiants

pubmed: 35260944
doi: 10.1007/s11657-021-00946-1
pii: 10.1007/s11657-021-00946-1
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

46

Informations de copyright

© 2022. International Osteoporosis Foundation and National Osteoporosis Foundation.

Références

Johnell O, Kanis JA (2006) An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 17(12):1726–1733
doi: 10.1007/s00198-006-0172-4 pubmed: 16983459
Hernlund E, Svedbom A, Ivergård M, Compston J, Cooper C, Stenmark J et al (2013) Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos 8:136
doi: 10.1007/s11657-013-0136-1 pubmed: 24113837 pmcid: 3880487
International Osteoporosis Foundation (2018) Broken bones, broken lives – fragility fractures in France. Burden, management and opportunities EU6, Summary Final Report 2018–06–26.[Internet]. [cited 2018 Dec 22]. Available from: https://www.iofbonehealth.org/broken-bones-broken-lives
Abimanyi-Ochom J, Watts JJ, Borgström F, Nicholson GC, Shore-Lorenti C, Stuart AL et al (2015) Changes in quality of life associated with fragility fractures: Australian arm of the International Cost and Utility Related to Osteoporotic Fractures Study (AusICUROS). Osteoporos Int 26(6):1781–1790
doi: 10.1007/s00198-015-3088-z pubmed: 25792491 pmcid: 4468793
Eekman DA, ter Wee MM, Coupé VMH, Erisek-Demirtas S, Kramer MH, Lems WF (2014) Indirect costs account for half of the total costs of an osteoporotic fracture: a prospective evaluation. Osteoporos Int 25(1):195–204
doi: 10.1007/s00198-013-2505-4 pubmed: 24072405
Hansen L, Mathiesen AS, Vestergaard P, Ehlers LH, Petersen KD (2013) A health economic analysis of osteoporotic fractures: who carries the burden? Arch Osteoporos 8:126
doi: 10.1007/s11657-013-0126-3 pubmed: 23420317 pmcid: 3880482
Hopkins RB, Burke N, Von Keyserlingk C, Leslie WD, Morin SN, Adachi JD et al (2016) The current economic burden of illness of osteoporosis in Canada. Osteoporos Int 27(10):3023–3032
doi: 10.1007/s00198-016-3631-6 pubmed: 27166680 pmcid: 5104559
Pike C, Birnbaum HG, Schiller M, Sharma H, Burge R, Edgell ET (2010) Direct and indirect costs of non-vertebral fracture patients with osteoporosis in the US. Pharmacoeconomics 28(5):395–409
doi: 10.2165/11531040-000000000-00000 pubmed: 20402541
Pisani P, Renna MD, Conversano F, Casciaro E, Di Paola M, Quarta E et al (2016) Major osteoporotic fragility fractures: risk factor updates and societal impact. World J Orthop 7(3):171–181
doi: 10.5312/wjo.v7.i3.171 pubmed: 27004165 pmcid: 4794536
Kim SC, Kim M-S, Sanfélix-Gimeno G, Song HJ, Liu J, Hurtado I et al (2015) Use of osteoporosis medications after hospitalization for hip fracture: a cross-national study. Am J Med 128(5):519-526.e1
doi: 10.1016/j.amjmed.2015.01.014 pubmed: 25660252 pmcid: 4414898
Thomas T, Gabach P, Buchon D et al (2015) Évaluation de la prise en charge avant et après hospitalisation pour fracture de fragilité en France à partir des données de la base SNIIRAM. Rev Rhum 82:A125 ((O116))
Briot K (2017) Fracture liaison services. Curr Opin Rheumatol 29(4):416–421
doi: 10.1097/BOR.0000000000000401 pubmed: 28426444
Wu C-H, Tu S-T, Chang Y-F, Chan D-C, Chien J-T, Lin C-H et al (2018) Fracture liaison services improve outcomes of patients with osteoporosis-related fractures: a systematic literature review and meta-analysis. Bone 111:92–100
doi: 10.1016/j.bone.2018.03.018 pubmed: 29555309
Portier A, Villoutreix C, Beaussier H, Grine A, Glippa S, Vilfaillot A, et al (2019) Implementation of a fracture liaison service an effective initiative to improve healthcare after osteoporotic hip or wrist fracture. Journal of Osteoporosis and Bone Research [Internet]. [cited 2019 Nov 14]; Available from: https://www.gavinpublishers.com/articles/research-article/Journal-of-Osteoporosis-and-Bone-Research/implementation-of-a-fracture-liaison-service-an-effective-initiative-to-improve-healthcare-after-osteoporotic-hip-or-wrist-fracture
Rotondi NK, Beaton DE, Ilieff M, Adhihetty C, Linton D, Bogoch E et al (2017) The impact of fragility fractures on work and characteristics associated with time to return to work. Osteoporos Int 28(1):349–358
doi: 10.1007/s00198-016-3730-4 pubmed: 27492487
Fujiwara S, Zhao X, Teoh C, Jaffe DH, Taguchi Y (2019) Disease burden of fractures among patients with osteoporosis in Japan: health-related quality of life, work productivity and activity impairment, healthcare resource utilization, and economic costs. J Bone Miner Metab 37(2):307–318
doi: 10.1007/s00774-018-0916-1 pubmed: 29520508
Borgström F, Karlsson L, Ortsäter G, Norton N, Halbout P, Cooper C et al (2020) Fragility fractures in Europe: burden, management and opportunities. Arch Osteoporos 15(1):59
doi: 10.1007/s11657-020-0706-y pubmed: 32306163 pmcid: 7166207
Brazier JE, Harper R, Jones NM et al (1992) Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ 305(6846):160–164
doi: 10.1136/bmj.305.6846.160 pubmed: 1285753 pmcid: 1883187
Cervantes CE, Gomez-Ulloa D, Elorriaga A, García JM, Md F, Tapias IC et al (2018) Productivity loss and local indirect costs associated with acute coronary syndrome and stroke in Spain. Value in Health 1(21):S102
doi: 10.1016/j.jval.2018.09.608
Carrera E, Mach F, Koskinas K, Lyrer P, Hullin R, Wanger C, Sidelnikov E (2019) Patient and caregiver productivity loss and indirect costs in the first year following cardiovascular events in Switzerland [Internet]. AGLA GSLA. [cited 2019 Nov 25]. Available from: http://www.agla-update.ch/2019/de/abstracts/p/2/11
Català Tella N, Serna Arnaiz C, Real Gatius J, Yuguero Torres O, Galván Santiago L (2017) Assessment of the length of sick leave in patients with ischemic heart disease. BMC Cardiovasc Disord [Internet]. [cited 2020 Apr 27];17. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5242005/
Arfi A, Baffert S, Soilly A-L, Huchon C, Reyal F, Asselain B, et al (2015) Determinants of return at work of breast cancer patients: results from the OPTISOINS01 French prospective study. BMJ Open. [cited 2020 Apr 27];8(5)
Stanghelle B et al (2019) Associations between health-related quality of life, physical function and pain in older women with osteoporosis and vertebral fracture. - PubMed - NCBI [Internet]. [cited 2019 Nov 14]. Available from: https://www.ncbi.nlm.nih.gov/pubmed/31684886

Auteurs

Agnès Portier (A)

Rheumatology Department, Groupe Hospitalier Paris Saint Joseph, 185 rue Raymond Losserand, 75014, Paris, France. agnesdanre@hotmail.com.

Mathilde Tissier (M)

Rheumatology Department, Groupe Hospitalier Paris Saint Joseph, 185 rue Raymond Losserand, 75014, Paris, France.

Caroline Villoutreix (C)

Rheumatology Department, Groupe Hospitalier Paris Saint Joseph, 185 rue Raymond Losserand, 75014, Paris, France.

Nadia Monrose (N)

Rheumatology Department, Groupe Hospitalier Paris Saint Joseph, 185 rue Raymond Losserand, 75014, Paris, France.

Hélène Beaussier (H)

Clinical Research Center, Groupe Hospitalier Paris Saint Joseph, Paris, France.

Julien Fournier (J)

Clinical Research Center, Groupe Hospitalier Paris Saint Joseph, Paris, France.

Franck Lin (F)

Clinical Research Center, Groupe Hospitalier Paris Saint Joseph, Paris, France.

Fabienne Roux (F)

Rheumatology Department, Groupe Hospitalier Paris Saint Joseph, 185 rue Raymond Losserand, 75014, Paris, France.

Thomas Huet (T)

Rheumatology Department, Groupe Hospitalier Paris Saint Joseph, 185 rue Raymond Losserand, 75014, Paris, France.

Julien Cohen-Solal (J)

Rheumatology Department, Groupe Hospitalier Paris Saint Joseph, 185 rue Raymond Losserand, 75014, Paris, France.

Gilles Hayem (G)

Rheumatology Department, Groupe Hospitalier Paris Saint Joseph, 185 rue Raymond Losserand, 75014, Paris, France.

Gilles Chatellier (G)

Clinical Research Center, Hôpital Européen Georges Pompidou, Paris, France.

Gérald Rajzbaum (G)

Rheumatology Department, Groupe Hospitalier Paris Saint Joseph, 185 rue Raymond Losserand, 75014, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH